Haemonetics
HAE
#2913
Rank
A$8.33 B
Marketcap
A$183.05
Share price
1.60%
Change (1 day)
60.14%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2026 (TTM): A$3.33

According to Haemonetics's latest financial reports the company's current EPS (TTM) is A$3.39. In 2025 the company made an earnings per share (EPS) of A$5.45 an increase over its 2024 EPS that were of A$3.82.

EPS history for Haemonetics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$3.33-38.95%
2025A$5.4542.68%
2024A$3.822.43%
2023A$3.7333.73%
2022A$2.79332.49%
2021A$0.64
2018A$1.33-363.15%
2017A-$0.51-207.1%
2016A$0.47-132.28%
2015A-$1.47-269%
2014A$0.87-20%
2013A$1.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.95 193.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$6.08 79.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
A$28.29 735.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.10-162.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$5.36 58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$14.08 315.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$11.47 238.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
A-$0.04470-101.32%๐Ÿ‡บ๐Ÿ‡ธ USA